doi.org/10.1084/jem....
Great collaboration with the group of Robert Zeiser linking microbiota-derived metabolites and central nervous system GVHD
@dmichonneau.bsky.social
MD, PhD, hematologist @hopitalsaintlouis.bsky.social Professor of hematology @upcite.bsky.social @INSERM @institut-leucemie.bsky.social UMR1342 https://www.institut-leucemie.fr/linstitut-de-la-leucemie-recherche/immunologie-translationnelle/
doi.org/10.1084/jem....
Great collaboration with the group of Robert Zeiser linking microbiota-derived metabolites and central nervous system GVHD
Great collaboration with Robert Zeiser @institut-leucemie.bsky.social @upcite.bsky.social @ap-hp.bsky.social @insermpresse.bsky.social Teduglutide for treatment-refractory severe intestinal acute graft-versus-host disease - a multicenter survey @springernature.com @BMT journal
rdcu.be/ehWV5
Happy to share our last paper, published with @springernature.com in @BMTjournal, about the French experience with belumosudil in the treatment of steroid-resistant cGvHD. Best ORR 57.4% including 14.7% of CR in patients who previously received at least 2 LOT
rdcu.be/efZg9
Congratulations to Sophie Le Grand for her very interesting paper in Hemasphere about the role of HLA evolutionary divergence score to predict outcome of prophylactic donor lymphocyte infusion after alloHSCT
doi.org/10.1002/hem3...
Systems-level immunomonitoring in children with solid tumors to enable precision medicine: Cell www.cell.com/cell/fulltex...
20.01.2025 19:03 — 👍 5 🔁 1 💬 0 📌 2